Solvates of Indomethacin

Indomethacin is known to exhibit polymorphism and solvates, the different forms obtained do not exhibit the same solubility and their bioavailabilities are different. It is of a prime importance to identify the various polymorphic and solvated forms. This study was carried out by: DSC (different scanning calorimetry), TG (thermogravimetric analysis), X-ray diffraction and thermomicroscopy. Seven solvates, with acetone, benzene, dichloromethane, tetrahydrofurane, propanol, chloroform and diethylether, were isolated and studied. Their formulae have been determined by thermogravimetric analysis and their X-ray patterns on powder are presented, by DSC their behaviour after desolvation is recorded, the temperature and the enthalpy of fusion are measured and by this way the form obtained is deduced. This revised version was published online in July 2006 with corrections to the Cover Date.     

Synthesis and crystal structure of new uranyl tungstates M2(UO2)(W2O8) (M=Na, K), M2(UO2)2(WO5)O (M=K, Rb), and Na10(UO2)8(W5O20)O8

The solid-state reactions of UO₃ and WO₃ with M₂CO₃ (M=Na, K, Rb) at 650°C for 5 days result, accordingly the starting stoichiometry, in the formation of M₂(UO₂)(W₂O₈) (M=Na (1), K (2)), M₂(UO₂)₂(WO₅)O (M=K (3), Rb (4)), and Na₁₀(UO₂)₈(W₅O₂₀)O₈ (5). The crystal structures of compounds 2, 3, 4, and 5 have been determined by single-crystal X-ray diffraction using Mo(Kα) radiation and a charge-coupled device detector. The crystal structures were solved by direct methods and Fourier difference techniques, and refined by a least-squares method on the basis of F² for all unique reflections. For (1), unit-cell parameters were determined from powder X-ray diffraction data. Crystallographic data: 1, monoclinic, a=12.736(4) Å, b=7.531(3) Å, c=8.493(3) Å, β=93.96(2)°, ρ_cal=6.62(2) g/cm³, ρ_mes=6.64(1) g/cm³, Z=4; 2, orthorhombic, space group Pmcn, a=7.5884(16) Å, b=8.6157(18) Å, c=13.946(3) Å, ρ_cal=6.15(2) g/cm³, ρ_mes=6.22(1) g/cm³, Z=8, R1=0.029 for 80 parameters with 1069 independent reflections; 3, monoclinic, space group P2₁/n, a=8.083(4) Å, b=28.724(5) Å, c=9.012(4) Å, β=102.14(1)°, ρ_cal=5.83(2) g/cm³, ρ_mes=5.90(2) g/cm³, Z=8, R1=0.037 for 171 parameters with 1471 reflections; 4, monoclinic, space group P2₁/n, a=8.234(1) Å, b=28.740(3) Å, c=9.378(1) Å, β=104.59(1)°, ρ_cal=6.13(2) g/cm³,  g/cm³, Z=8, R1=0.037 for 171 parameters with 1452 reflections; 5, monoclinic, space group C2/c, a=24.359(5) Å, b=23.506(5) Å, c=6.8068(14) Å, β=94.85(3)°, ρ_cal=6.42(2) g/cm³,  g/cm³, Z=8, R1=0.036 for 306 parameters with 5190 independent reflections. The crystal structure of 2 contains linear one-dimensional chains formed from edge-sharing UO₇ pentagonal bipyramids connected by two octahedra wide (W₂O₈) ribbons formed from two edge-sharing WO₆ octahedra connected together by corners. This arrangement leads to [UW₂O₁₀]²⁻ corrugated layers parallel to (001). Owing to the unit-cell parameters, compound 1 probably contains similar sheets parallel to (100). Compounds 3 and 4 are isostructural and the structure consists of bi-dimensional networks built from the edge- and corner-sharing UO₇ pentagonal bipyramids. This arrangement creates square sites occupied by W atoms, a fifth oxygen atom completes the coordination of W atoms to form WO₅ distorted square pyramids. The interspaces between the resulting [U₂WO₁₀]²⁻ layers parallel to plane are occupied by K or Rb atoms. The crystal structure of compound 5 is particularly original. It is based upon layers formed from UO₇ pentagonal bipyramids and two edge-shared octahedra units, W₂O₁₀, by the sharing of edges and corners. Two successive layers stacked along the [100] direction are pillared by WO₄ tetrahedra resulting in sheets of double layers. The sheets are separated by Na⁺ ions. The other Na⁺ ions occupy the rectangular tunnels created within the sheets. In fact complex anions W₅O₂₀¹⁰⁻ are built by the sharing of the four corners of a WO₄ tetrahedron with two W₂O₁₀ dimmers, so, the formula of compound 5 can be written Na₁₀(UO₂)₈(W₅O₂₀)O₈.     

Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases leading to dementia. Despite research efforts, currently there are no effective pharmacotherapeutic options for the prevention and treatment of AD. Recently, numerous studies highlighted the beneficial effects of curcumin (CUR), a natural polyphenol, in the neuroprotection. Especially, its dual antioxidant and anti-inflammatory properties attracted the interest of researchers. In fact, besides its antioxidant and anti-inflammatory properties, this biomolecule is not degraded in the intestinal tract. Additionally, CUR is able to cross the blood–brain barrier and could therefore to be used to treat neurodegenerative pathologies associated with oxidative stress, inflammation and apoptosis. The present study aimed to assess the ability of CUR to induce neuronal protective and/or recovery effects on a rat model of neurotoxicity induced by aluminum chloride (AlCl₃), which mimics the sporadic form of Alzheimer’s disease. Our results showed that treatment with CUR enhances pro-oxidant levels, antioxidant enzymes activities and anti-inflammatory cytokine production and decreases apoptotic cells in AlCl₃-exposed hippocampus rats. Additionally, histopathological analysis of hippocampus revealed the potential of CUR in decreasing the hallmarks in the AlCl₃-induced AD. We also showed that CUR post-treatment significantly improved the behavioral, oxidative stress and inflammation in AlCl₃-exposed rats. Taken together, our data presented CUR as a nutraceutical potential through its protective effects that are more interesting than recovery ones in sporadic model of AD.     

ChemInform Abstract: From 1∞ [(UO2)2O(MoO4)4]6‐ to 1∞ [(UO2)2(MoO4)3(MoO5)] 6‐ Infinite Chains in A6U2Mo4O21 (A: Na,K, Rb,Cs) Compounds: Synthesis and Crystal Structure of Cs6 [(UO2)2(MoO4)3(MoO5)] .

Single crystals of the title compound are obtained from a melt of U₃O₈, MoO₃, and excess Cs₂CO₃ (Pt crucible, 950 °C, 12 h, cooling rate 5 °C/h).     

A comparison of plasma and electron beam-sterilization of PU catheters

Polyurethane (PU) catheters made of Pellethane 2363-80AE^® were treated in two different ways: a new treatment with low temperature plasma that could be used to decontaminate reusable polymer devices in hospitals, and an e-beam (EB) irradiation. Polymer structure and bulk properties were studied by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), infrared spectroscopy (FTIR) and size exclusion chromatography (SEC). Although PU was strongly modified by the e-beam irradiation leading to branching of polymer chains, it had no or little impact on the thermo-mechanical properties of the catheters and on the hard/soft segment organization of PU. For plasma-treated samples, no modification in the polymer bulk was observed, confirming that plasma treatment might be considered as an alternative to e-beam irradiation. The analysis of surface modifications showed an evolution of superficial topology and chemical composition (grafting of oxygen and nitrogen species) of the catheters after treatment, with a more polar and hydrophilic surface.     

A new uranyl niobate sheet in the cesium uranyl niobate Cs9[(UO2)8O4(NbO5)(Nb2O8)2]

A new cesium uranyl niobate, Cs₉[(UO₂)₈O₄(NbO₅)(Nb₂O₈)₂] or Cs₉U₈Nb₅O₄₁ has been synthesized by high-temperature solid-state reaction, using a mixture of U₃O₈, Cs₂CO₃ and Nb₂O₅. Single crystals were obtained by incongruent melting of a starting mixture with metallic ratio=Cs/U/Nb=1/1/1. The crystal structure of the title compound was determined from single crystal X-ray diffraction data, and solved in the monoclinic system with the following crystallographic data: a=16.729(2) Å, b=14.933(2) Å, c=20.155(2) Å β=110.59(1)°, P2₁/c space group and Z=4. The crystal structure was refined to agreement factors R₁=0.049 and wR₂=0.089, calculated for 4660 unique observed reflections with I?2σ(I), collected on a BRUKER AXS diffractometer with MoKα radiation and a CCD detector.In this structure the UO₇ uranyl pentagonal bipyramids are connected by sharing edges and corners to form a uranyl layer corresponding to a new anion-sheet topology, and creating triangular, rectangular and square vacant sites. The two last sites are occupied by Nb₂O₈ entities and NbO₅ square pyramids, respectively, to form infinite uranyl niobate sheets stacking along the [010] direction. The Nb₂O₈ entities result from two edge-shared NbO₅ square pyramids. The Cs⁺ cations are localized between layers and ensured the cohesion of the structure.The cesium cation mobility between the uranyl niobate sheets was studied by electrical measurements. The conductivity obeys the Arrhenius law in all the studied temperature domains. The observed low conductivity values with high activation energy may be explained by the strong connection of the Cs⁺ cations to the infinite uranyl niobate layers and by the high density of these cations in the interlayer space without vacant site.Infrared spectroscopy investigated at room temperature in the frequency range 400-4000 cm⁻¹, showed some characteristic bands of uranyl ion and niobium polyhedra.     

AaTs-1: A Tetrapeptide from Androctonus australis Scorpion Venom,Inhibiting U87 Glioblastoma Cells Proliferation by p53 and FPRL-1 Up-Regulations

Glioblastoma is an aggressive cancer, against which medical professionals are still quite helpless, due to its resistance to current treatments. Scorpion toxins have been proposed as a promising alternative for the development of effective targeted glioblastoma therapy and diagnostic. However, the exploitation of the long peptides could present disadvantages. In this work, we identified and synthetized AaTs-1, the first tetrapeptide from Androctonus australis scorpion venom (Aa), which exhibited an antiproliferative effect specifically against human glioblastoma cells. Both the native and synthetic AaTs-1 were endowed with the same inhibiting effect on the proliferation of U87 cells with an IC₅₀ of 0.56 mM. Interestingly, AaTs-1 was about two times more active than the anti-glioblastoma conventional chemotherapeutic drug, temozolomide (TMZ), and enhanced its efficacy on U87 cells. AaTs-1 showed a significant similarity with the synthetic peptide WKYMVm, an agonist of a G-coupled formyl-peptide receptor, FPRL-1, known to be involved in the proliferation of glioma cells. Interestingly, the tetrapeptide triggered the dephosphorylation of ERK, p38, and JNK kinases. It also enhanced the expression of p53 and FPRL-1, likely leading to the inhibition of the store operated calcium entry. Overall, our work uncovered AaTs-1 as a first natural potential FPRL-1 antagonist, which could be proposed as a promising target to develop new generation of innovative molecules used alone or in combination with TMZ to improve glioblastoma treatment response. Its chemical synthesis in non-limiting quantity represents a valuable advantage to design and develop low-cost active analogues to treat glioblastoma cancer.     

Pb(UO2)(V2O7), a novel lead uranyl divanadate

A new lead uranyl divanadate, PbUO₂(V₂O₇), has been synthesized by high temperature solid-state reaction and its crystal structure was solved by direct methods using single-crystal X-ray diffraction data. It crystallizes in the monoclinic system with space group P2₁/n and following cell parameters: a=6.9212(9) Å, b=9.6523(13) Å, c=11.7881(16) Å, β=91.74(1)°, V=787.01(2) Å³, Z=4, ρ_mes=5.82(3), ρ_cal=5.83(1) g/cm³. A full-matrix least-squares refinement on the basis of F² yielded R₁=0.029 and wR₂=0.064 for 2136 independent reflections with I>2σ(I) collected with a Bruker AXS diffractometer (MoKα radiation). The crystal structure of PbUO₂(V₂O₇) consists of a tri-dimensional framework resulting from the association of V₂O₇ divanadate units formed by two VO₄ tetrahedra sharing corner and UO₇ uranyl pentagonal bipyramids and creating one-dimensional elliptic channels occupied by the Pb²⁺ ions. In PbUO₂(V₂O₇), infinite ribbons of four pentagons wide are formed which can be deduced from the sheets with Uranophane type anion-topology that occurs, for example, in the uranyl divanadate (UO₂)₂(V₂O₇), by replacement of half-U atoms of the edge-shared UO₇ pentagonal bipyramids by Pb atoms. Infrared spectroscopy was investigated at room temperature in the frequency range 400-4000 cm⁻¹, showing some characteristic bands of uranyl ion and of VO₄ tetrahedra.     

Contribution of size exclusion chromatography and thermal analysis methods in the study of the radiochemical behavior of plastic materials

Sterilization by irradiation techniques is considered to be an improved method to treat polluted products of human consumption. Secondary effects, that may be generated in the components of packaging materials, could induce organoleptic damage and some physico-chemical modifications, observed especially in plastic materials. In order to demonstrate any such secondary changes, we have investigated the effects of beta-irradiation (a treatment which could induce either a reticulation or a cleavage in a polymeric sequence) on three polymers; namely, low density polyethylene, polystyrene and polyvinyl chloride. The techniques used to identify irradiation-induced modifications of these polymers were size exclusion chromatography and thermal analysis. Thermal analysis showed a decrease in the percentage of crystallinity of polyethylene after its radiosterilization. Exclusion chromatography highlighted a reticulation for irradiated polyvinyl chloride and polystyrene.     

Selective Halogenation of L-Sorbose Derivatives

Abstract

Deoxyhalogenosugars constitute an important class of compounds for the synthesis of other carbohydrate derivatives.^1–3 Several members of this class are of interest in their own right, being intensely sweet^{4, 5} or possessing anti-cariogenic^6,7 or male anti-fertility properties.^8–11